Allyson Kinzel named senior vice president and chief legal officer at MD Anderson

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

MD Anderson Cancer Center has named Allyson Hancock Kinzel as senior vice president and chief legal officer, effective Nov. 1.

Kinzel will lead legal and regulatory affairs in her role after serving as chief legal officer since 2018. She will report to the president and will be a member of the institution’s executive leadership team.

As senior vice president, Kinzel will oversee three legal and regulatory departments: Legal Services, Internal Audit and the Office of Institutional Compliance. Kinzel will be responsible for identifying and managing risk across the institution, leading auditing and monitoring efforts and ensuring the institution’s compliance with federal and state laws. As chief legal officer, she has guided responses to hospital-wide federal regulatory surveys, established MD Anderson’s institutional conflict of interest policy and program structure and led the institution’s response to the Office for Civil Rights regarding federal enforcement provisions.

Before serving as chief legal officer, Kinzel worked for 10 years in Institutional Compliance at MD Anderson and was vice president and chief compliance and ethics officer from 2014 to 2018. Prior to coming to MD Anderson, Kinzel represented health care providers as a partner at Baker Hostetler, LLP, and as an attorney at Vinson and Elkins, LLP.

YOU MAY BE INTERESTED IN

Cell and gene therapies have made incredible strides over the past decade. The 2024 FDA approvals of the first T-cell receptor therapy for the treatment of metastatic synovial sarcoma and the first tumor-infiltrating lymphocyte therapy for the treatment of unresectable or metastatic melanoma mark a significant turning point for solid tumor treatment.xxx:more
The intersection of diabetes, obesity and cancer represents an important and underappreciated challenge in medicine. Apart from smoking, overweight is now the leading modifiable risk factor for cancer. With the global epidemic of overweight and diabetes driving cancer incidence across multiple organ sites, understanding the metabolic underpinnings of this relationship has never been more critical.
The Pazdurs in their garden with their dog, Cleo. The dog’s full name is Cleopatra, Queen of Denial.In 1999, Rick Pazdur went in for a “perfunctory” final interview at FDA. Thinking it would only take a few minutes, his wife, Mary, decided to wait and have a quick cup of coffee at a nearby restaurant—Hooters.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login